カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗肥満治療薬市場2022年：末梢性抗肥満薬、中枢性抗肥満薬

◆英語タイトル：Global Anti-obesity Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8737）◆商品コード：GIR22MY8737
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

抗肥満治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗肥満治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗肥満治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・末梢性抗肥満薬、中枢性抗肥満薬

用途別セグメントは次のように区分されます。
・子供用、大人用

世界の抗肥満治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Novo Nordisk、Pfizer、Arena Pharmaceuticals、Roche、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Amylin、Alizyme、Boehringer Ingelheim、Eisai

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗肥満治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗肥満治療薬メーカーの企業概要、2019年～2022年までの抗肥満治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗肥満治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗肥満治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗肥満治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗肥満治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗肥満治療薬の産業チェーンを掲載しています。
・第13、14、15章では、抗肥満治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck、Novo Nordisk、Pfizer、Arena Pharmaceuticals、Roche、GlaxoSmithKline、Orexigen Therapeutics、Vivus、Amylin、Alizyme、Boehringer Ingelheim、Eisai
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：末梢性抗肥満薬、中枢性抗肥満薬
・用途別分析2017年-2028年：子供用、大人用
・抗肥満治療薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・抗肥満治療薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・抗肥満治療薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・抗肥満治療薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・抗肥満治療薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti-obesity Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-obesity Drugs market size is estimated to be worth US$ 1876.9 million in 2021 and is forecast to a readjusted size of USD 5385.2 million by 2028 with a CAGR of 16.2% during review period. Kids accounting for % of the Anti-obesity Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peripherally Acting Anti-obesity Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-obesity Drugs include Merck, Novo Nordisk, Pfizer, Arena Pharmaceuticals, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-obesity Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market segment by Application can be divided into
Kids
Adults
The key market players for global Anti-obesity Drugs market are listed below:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-obesity Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-obesity Drugs, with price, sales, revenue and global market share of Anti-obesity Drugs from 2019 to 2022.
Chapter 3, the Anti-obesity Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-obesity Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-obesity Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-obesity Drugs.
Chapter 13, 14, and 15, to describe Anti-obesity Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Anti-obesity Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-obesity Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Peripherally Acting Anti-obesity Drugs
1.2.3 Centrally Acting Anti-obesity Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-obesity Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Kids
1.3.3 Adults
1.4 Global Anti-obesity Drugs Market Size & Forecast
1.4.1 Global Anti-obesity Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-obesity Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti-obesity Drugs Price (2017-2028)
1.5 Global Anti-obesity Drugs Production Capacity Analysis
1.5.1 Global Anti-obesity Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti-obesity Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-obesity Drugs Market Drivers
1.6.2 Anti-obesity Drugs Market Restraints
1.6.3 Anti-obesity Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Anti-obesity Drugs Product and Services
2.1.4 Merck Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Anti-obesity Drugs Product and Services
2.2.4 Novo Nordisk Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Anti-obesity Drugs Product and Services
2.3.4 Pfizer Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Arena Pharmaceuticals
2.4.1 Arena Pharmaceuticals Details
2.4.2 Arena Pharmaceuticals Major Business
2.4.3 Arena Pharmaceuticals Anti-obesity Drugs Product and Services
2.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Anti-obesity Drugs Product and Services
2.5.4 Roche Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Anti-obesity Drugs Product and Services
2.6.4 GlaxoSmithKline Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Orexigen Therapeutics
2.7.1 Orexigen Therapeutics Details
2.7.2 Orexigen Therapeutics Major Business
2.7.3 Orexigen Therapeutics Anti-obesity Drugs Product and Services
2.7.4 Orexigen Therapeutics Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Vivus
2.8.1 Vivus Details
2.8.2 Vivus Major Business
2.8.3 Vivus Anti-obesity Drugs Product and Services
2.8.4 Vivus Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amylin
2.9.1 Amylin Details
2.9.2 Amylin Major Business
2.9.3 Amylin Anti-obesity Drugs Product and Services
2.9.4 Amylin Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Alizyme
2.10.1 Alizyme Details
2.10.2 Alizyme Major Business
2.10.3 Alizyme Anti-obesity Drugs Product and Services
2.10.4 Alizyme Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Anti-obesity Drugs Product and Services
2.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Eisai
2.12.1 Eisai Details
2.12.2 Eisai Major Business
2.12.3 Eisai Anti-obesity Drugs Product and Services
2.12.4 Eisai Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-obesity Drugs Breakdown Data by Manufacturer
3.1 Global Anti-obesity Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-obesity Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-obesity Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-obesity Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-obesity Drugs Manufacturer Market Share in 2021
3.5 Global Anti-obesity Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-obesity Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-obesity Drugs Market Size by Region
4.1.1 Global Anti-obesity Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-obesity Drugs Revenue by Region (2017-2028)
4.2 North America Anti-obesity Drugs Revenue (2017-2028)
4.3 Europe Anti-obesity Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti-obesity Drugs Revenue (2017-2028)
4.5 South America Anti-obesity Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti-obesity Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-obesity Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti-obesity Drugs Revenue by Type (2017-2028)
5.3 Global Anti-obesity Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-obesity Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti-obesity Drugs Revenue by Application (2017-2028)
6.3 Global Anti-obesity Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-obesity Drugs Sales by Type (2017-2028)
7.2 North America Anti-obesity Drugs Sales by Application (2017-2028)
7.3 North America Anti-obesity Drugs Market Size by Country
7.3.1 North America Anti-obesity Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-obesity Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-obesity Drugs Sales by Type (2017-2028)
8.2 Europe Anti-obesity Drugs Sales by Application (2017-2028)
8.3 Europe Anti-obesity Drugs Market Size by Country
8.3.1 Europe Anti-obesity Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-obesity Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-obesity Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-obesity Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-obesity Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-obesity Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-obesity Drugs Sales by Type (2017-2028)
10.2 South America Anti-obesity Drugs Sales by Application (2017-2028)
10.3 South America Anti-obesity Drugs Market Size by Country
10.3.1 South America Anti-obesity Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-obesity Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-obesity Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-obesity Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-obesity Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-obesity Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-obesity Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-obesity Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-obesity Drugs
12.3 Anti-obesity Drugs Production Process
12.4 Anti-obesity Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-obesity Drugs Typical Distributors
13.3 Anti-obesity Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Anti-obesity Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-obesity Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Anti-obesity Drugs Product and Services
Table 6. Merck Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Major Business
Table 9. Novo Nordisk Anti-obesity Drugs Product and Services
Table 10. Novo Nordisk Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Anti-obesity Drugs Product and Services
Table 14. Pfizer Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Arena Pharmaceuticals Major Business
Table 17. Arena Pharmaceuticals Anti-obesity Drugs Product and Services
Table 18. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche Anti-obesity Drugs Product and Services
Table 22. Roche Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Anti-obesity Drugs Product and Services
Table 26. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Orexigen Therapeutics Major Business
Table 29. Orexigen Therapeutics Anti-obesity Drugs Product and Services
Table 30. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Vivus Basic Information, Manufacturing Base and Competitors
Table 32. Vivus Major Business
Table 33. Vivus Anti-obesity Drugs Product and Services
Table 34. Vivus Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amylin Basic Information, Manufacturing Base and Competitors
Table 36. Amylin Major Business
Table 37. Amylin Anti-obesity Drugs Product and Services
Table 38. Amylin Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Alizyme Basic Information, Manufacturing Base and Competitors
Table 40. Alizyme Major Business
Table 41. Alizyme Anti-obesity Drugs Product and Services
Table 42. Alizyme Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Anti-obesity Drugs Product and Services
Table 46. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Eisai Basic Information, Manufacturing Base and Competitors
Table 48. Eisai Major Business
Table 49. Eisai Anti-obesity Drugs Product and Services
Table 50. Eisai Anti-obesity Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Anti-obesity Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Anti-obesity Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Anti-obesity Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Anti-obesity Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Anti-obesity Drugs Production Site of Key Manufacturer
Table 56. Anti-obesity Drugs New Entrant and Capacity Expansion Plans
Table 57. Anti-obesity Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Global Anti-obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Global Anti-obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Anti-obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Global Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Global Anti-obesity Drugs Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Anti-obesity Drugs Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Anti-obesity Drugs Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Anti-obesity Drugs Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Global Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Global Anti-obesity Drugs Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Anti-obesity Drugs Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Anti-obesity Drugs Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Anti-obesity Drugs Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 75. North America Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 76. North America Anti-obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Anti-obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 79. North America Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 80. North America Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 81. North America Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Anti-obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Anti-obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Europe Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Europe Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Europe Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Anti-obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Anti-obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Anti-obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 98. South America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 99. South America Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 100. South America Anti-obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Anti-obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 103. South America Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 104. South America Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 105. South America Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Anti-obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Anti-obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Anti-obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Anti-obesity Drugs Raw Material
Table 115. Key Manufacturers of Anti-obesity Drugs Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Anti-obesity Drugs Typical Distributors
Table 119. Anti-obesity Drugs Typical Customers
List of Figures
Figure 1. Anti-obesity Drugs Picture
Figure 2. Global Anti-obesity Drugs Revenue Market Share by Type in 2021
Figure 3. Peripherally Acting Anti-obesity Drugs
Figure 4. Centrally Acting Anti-obesity Drugs
Figure 5. Global Anti-obesity Drugs Revenue Market Share by Application in 2021
Figure 6. Kids
Figure 7. Adults
Figure 8. Global Anti-obesity Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Anti-obesity Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Anti-obesity Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Anti-obesity Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Anti-obesity Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Anti-obesity Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Anti-obesity Drugs Market Drivers
Figure 15. Anti-obesity Drugs Market Restraints
Figure 16. Anti-obesity Drugs Market Trends
Figure 17. Global Anti-obesity Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Anti-obesity Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Anti-obesity Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Anti-obesity Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Anti-obesity Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Anti-obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Anti-obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Anti-obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Anti-obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Anti-obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Anti-obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Anti-obesity Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Anti-obesity Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Anti-obesity Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Anti-obesity Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Anti-obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Anti-obesity Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Anti-obesity Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Anti-obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Anti-obesity Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Anti-obesity Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Anti-obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Anti-obesity Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Anti-obesity Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Anti-obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Anti-obesity Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Anti-obesity Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Anti-obesity Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Anti-obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Anti-obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Anti-obesity Drugs in 2021
Figure 76. Manufacturing Process Analysis of Anti-obesity Drugs
Figure 77. Anti-obesity Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の抗肥満治療薬市場2022年：末梢性抗肥満薬、中枢性抗肥満薬(Global Anti-obesity Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 抗呼吸器合胞体ウイルス薬のグローバル市場予測2023-2029
  • かゆみ止め薬のグローバル市場予測2023-2029
  • 世界の肥満治療装置市場2022年：胃バンディングシステム、胃バルーンシステム、胃電気刺激システム、胃排出システム／胃吸引システム、その他
  • 世界の抗不安剤市場2022年：特許医薬品、ジェネリック医薬品、その他
  • 世界の動物用感染症治療薬市場2022年：抗菌剤、抗ウイルス剤、抗真菌剤、その他